FOXO1 and metabolic dysfunction-associated steatotic liver disease: Induction of hepatic FoxO1 expression may provide an effective strategy for raising hepatic triglyceride catabolism, thereby probably preventing hepatic triglyceride accumulation and obesity-associated NAFLD.